Altogether, these results suggest that the deletion of Atg5 in CD11c+ cells activates IL-23 secretion likely in a p38/ NF-κB-dependent manner, inducing insulin resistance and NAFLD development. Here, ITGAX is linked to metabolic dysfunction-associated steatotic liver disease.